Relief Therapeutics Holding SA (OTCMKTS:RLFTF) Sees Large Decrease in Short Interest

Relief Therapeutics Holding SA (OTCMKTS:RLFTF) was the target of a large drop in short interest during the month of April. As of April 15th, there was short interest totalling 1,700 shares, a drop of 82.3% from the March 31st total of 9,600 shares. Based on an average trading volume of 4,100 shares, the days-to-cover ratio is presently 0.4 days.

Relief Therapeutics Stock Performance

OTCMKTS RLFTF remained flat at $1.45 during trading on Friday. 425 shares of the company were exchanged, compared to its average volume of 2,789. Relief Therapeutics has a 52-week low of $1.20 and a 52-week high of $9.00. The firm’s fifty day moving average is $1.59 and its 200-day moving average is $1.95.

Relief Therapeutics Company Profile

Relief Therapeutics Holding AG, a biopharmaceutical company, focuses on identification, development, and commercialization of novel, patent protected products for the treatment of metabolic, dermatological, and pulmonary rare diseases in Switzerland, Europe, North America, and internationally. The company offers SETOFILM/ONDISSOLVE for radiotherapy induced nausea and vomiting, and chemotherapy induced nausea and vomiting, as well as postoperative induced nausea and vomiting.